Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson's Disease

被引：1
|
作者：
Sabnis, Ram W. [1 ]
机构：
[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2022年
关键词：
D O I：
10.1021/acsmedchemlett.1c00687
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting LRRK2 mutations in Parkinson's disease
    Lesniak, Robert K.
    Nichols, Robert Jeremy
    Smith, Mark
    Montine, Thomas J.
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1167 - 1170
  • [32] LRRK2 and the Endolysosomal System in Parkinson's Disease
    Erb, Madalynn L.
    Moore, Darren J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291
  • [33] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [34] Lrrk2 pathogenic substitutions in Parkinson's disease
    Ignacio F. Mata
    Jennifer M. Kachergus
    Julie P. Taylor
    Sarah Lincoln
    Jan Aasly
    Timothy Lynch
    Mary M. Hulihan
    Stephanie A. Cobb
    Ruey-Meei Wu
    Chin-Song Lu
    Carlos Lahoz
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2005, 6 : 171 - 177
  • [35] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [36] A novel LRRK2 mutation in an austrian cohort of patients with Parkinson's disease
    Haubenberger, Dietrich
    Bonelli, Silvia
    Hotzy, Christoph
    Leitner, Petra
    Lichtner, Peter
    Samal, Doris
    Katzenschlager, Regina
    Djamshidian, Albin
    Bruecke, Thomas
    Steffelbauer, Michaela
    Bancher, Christian
    Grossmann, Josef
    Ransmayr, Gerhard
    Strom, Tim M.
    Meitinger, Thomas
    Gasser, Thomas
    Auff, Eduard
    Zimprich, Alexander
    MOVEMENT DISORDERS, 2007, 22 (11) : 1640 - 1643
  • [37] Pathological Functions of LRRK2 in Parkinson's Disease
    Jeong, Ga Ram
    Lee, Byoung Dae
    CELLS, 2020, 9 (12) : 1 - 19
  • [38] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [39] Using computer modeling to find new LRRK2 inhibitors for parkinson’s disease
    María C. García
    Sebastián A. Cuesta
    José R. Mora
    Jose L. Paz
    Yovani Marrero-Ponce
    Frank Alexis
    Edgar A. Márquez
    Scientific Reports, 15 (1)
  • [40] Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
    Nichols, R. Jeremy
    Dzamko, Nicolas
    Hutti, Jessica E.
    Cantley, Lewis C.
    Deak, Maria
    Moran, Jennifer
    Bamborough, Paul
    Reith, Alastair D.
    Alessi, Dario R.
    BIOCHEMICAL JOURNAL, 2009, 424 : 47 - 60
12345